Due to the limited number of studies and the fact that most data were derived from the second and third trimesters of pregnancy, additional research is necessary to validate the conclusions, investigate the potential of FGF21 in enabling early diagnosis, and further examine the role of FGF21 in the development and progression of GDM/PE. The gene discussed is FGF21; the disease is gestational diabetes.